Literature DB >> 20713358

Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.

Mitsuo Kato1, Lin Wang, Sumanth Putta, Mei Wang, Hang Yuan, Guangdong Sun, Linda Lanting, Ivan Todorov, John J Rossi, Rama Natarajan.   

Abstract

Increased accumulation of extracellular matrix proteins and hypertrophy induced by transforming growth factor-β1 (TGF-β) in renal mesangial cells (MC) are hallmark features of diabetic nephropathy. Although the post-transcriptional regulation of key genes has been implicated in these events, details are not fully understood. Here we show that TGF-β increased microRNA-216a (miR-216a) levels in mouse MC, with parallel down-regulation of Ybx1, a miR-216a target and RNA-binding protein. TGF-β also enhanced protein levels of Tsc-22 (TGF-β-stimulated clone 22) and collagen type I α-2 (Col1a2) expression in MC through far upstream enhancer E-boxes by interaction of Tsc-22 with an E-box regulator, Tfe3. Ybx1 colocalized with processing bodies in MC and formed a ribonucleoprotein complex with Tsc-22 mRNA, and this complex formation was reduced by TGF-β, miR-216a mimics, or Ybx1 shRNA to increase Tsc-22 protein levels but enhanced by miR-216a inhibitor oligonucleotides. Chromatin immunoprecipitation (ChIP) assays revealed that TGF-β could increase the occupancies of Tsc-22 and Tfe3 on enhancer E-boxes of Col1a2. Co-immunoprecipitation assays revealed that TGF-β promoted the interaction of Tsc-22 with Tfe3. These results demonstrate that post-transcriptional regulation of Tsc-22 mediated through Ybx1, a miR-216a target, plays a key role in TGF-β-induced Col1a2 in MC related to the pathogenesis of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713358      PMCID: PMC2962500          DOI: 10.1074/jbc.M110.165027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Regulation of mRNA translation in renal physiology and disease.

Authors:  Balakuntalam S Kasinath; Denis Feliers; Kavithalakshmi Sataranatarajan; Goutam Ghosh Choudhury; Myung Ja Lee; Meenalakshmi M Mariappan
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

2.  The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation.

Authors:  R Sekido; K Murai; J Funahashi; Y Kamachi; A Fujisawa-Sehara; Y Nabeshima; H Kondoh
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

3.  Tsc-22 enhances TGF-beta signaling by associating with Smad4 and induces erythroid cell differentiation.

Authors:  So-Jung Choi; Jae-Hoon Moon; Young-Wook Ahn; Jin-Hyun Ahn; Dong-Uk Kim; Tae-Hee Han
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

4.  SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.

Authors:  K Verschueren; J E Remacle; C Collart; H Kraft; B S Baker; P Tylzanowski; L Nelles; G Wuytens; M T Su; R Bodmer; J C Smith; D Huylebroeck
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 6.  MicroRNA control of signal transduction.

Authors:  Masafumi Inui; Graziano Martello; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03-10       Impact factor: 94.444

7.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

8.  Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.

Authors:  Shuxia Wang; Jim Skorczewski; Xu Feng; Lin Mei; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

9.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  86 in total

Review 1.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

2.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 3.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

Review 4.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

5.  A MicroRNA Cluster miR-23-24-27 Is Upregulated by Aldosterone in the Distal Kidney Nephron Where it Alters Sodium Transport.

Authors:  Xiaoning Liu; Robert S Edinger; Christine A Klemens; Yu L Phua; Andrew J Bodnar; William A LaFramboise; Jacqueline Ho; Michael B Butterworth
Journal:  J Cell Physiol       Date:  2017-01-05       Impact factor: 6.384

Review 6.  Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Authors:  Juliana Inês Santos; Ana Luísa Teixeira; Francisca Dias; Mónica Gomes; Augusto Nogueira; Joana Assis; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-25

Review 7.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 8.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

9.  Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.

Authors:  Hongmei Zhu; Siu Wai Leung
Journal:  Diabetologia       Date:  2015-02-13       Impact factor: 10.122

Review 10.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.